VENTAC PARTNERS IS A DEDICATED LIFE SCIENCE CONSULTING FIRM WITH OFFICES IN EUROPE, USA AND ASIA.

Ventac Partners has a strong track record in founding new innovative companies, strategic and operational market and product analysis, intellectual property development, fund raising, licensing, M&A and strategy consulting.

All partners are experienced executives from pharma, biotech and medtech companies, and preclinical, clinical and regulatory, legal and intellectual property experts with extensive backgrounds in successfully starting, growing and expanding international life science companies.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Latest News
August, 2014 | Santaris Pharma, a pioneer in the emerging era of RNA-targeting therapeutics, signs acquisition agreement with Roche, see Portfolio News.

July, 2014 | Miacom Diagnostics GmbH teams up with Fosun Diagnostics, a Diagnostic Division of Shanghai Fosun Pharmaceutical Group, see Portfolio News.

May, 2014 | Ventac Partners organizes a biotech entrepreneurship  course at the Asia BioInvest 2014 conference in Hong Kong (June 3).

April, 2014 | RhoVac Aps and Ventac Partners enter in agreement to develop therapeutic vaccines based on RhoC peptides towards first-in-man clinical trials, see Portfolio News.

 

Newsblitz

Clinical Network Services (CNS) Pty Ltd
Clinical Network Services (CNS), an integrated service consultancy focusing on preclinical and early clinical project implementation and Ventac Partners sign cooperative partnership to provide joint services to global clients (download services flyer here).

For more information, see our joint press release.